- 関
- receptor activator of nuclear factor-kappa B、receptor activator of nuclear factor-kappaB
- 同
- receptor activator for nuclear factor kB
WordNet
- very offensive in smell or taste; "a rank cigar"
- relative status; "his salary was determined by his rank and seniority"
- a row or line of people (especially soldiers or police) standing abreast of one another; "the entrance was guarded by ranks of policemen"
- take precedence or surpass others in rank (同)outrank
- growing profusely; "rank jungle vegetation"
- take or have a position relative to others; "This painting ranks among the best in the Western World"
- very fertile; producing profuse growth; "rank earth"
PrepTutorEJDIC
- 〈C〉〈U〉『階級』,等級;)相対的な)『順位』,地位: / 〈U〉高い地位(身分) / 〈C〉〈U〉(人・物の)『列』,並び;(兵隊)の横列 / 《the ranks》(また『rank and file』)(将校たちに対して)兵卒,下士官 / …‘を'『並べる』 / …‘を'『位置づける』,評価する / 《米》…‘より'上位にある / 『位置する』・「pull one's rank on 誰々」で「(誰々に)地位を悪用する; (意見が衝突したような場合に)階級をかさに着て(誰々に)命令を押しつける」
- (植物が)おい茂った,はびこった / (土地が)植物をおい茂らせた,肥えすぎた;(土地が)(植物を)おい茂らせた《+『with』+『名』》 / 悪臭を放つ,いやな味のする / 全くの,ひどい
- Regular Army正規軍
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/02/05 20:54:36」(JST)
[Wiki en表示]
Not to be confused with RANKL, the osteoclast cell-surface receptor that binds to RANK.
For other uses, see Rank (disambiguation).
| Tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
| Available structures |
| PDB |
Ortholog search: PDBe, RCSB |
| List of PDB id codes |
|
1LB5
|
|
|
| Identifiers |
| Symbols |
TNFRSF11A; CD265; FEO; LOH18CR1; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TRANCER |
| External IDs |
OMIM: 603499 MGI: 1314891 HomoloGene: 2848 GeneCards: TNFRSF11A Gene |
| Gene Ontology |
| Molecular function |
• receptor activity
• transmembrane signaling receptor activity
• tumor necrosis factor-activated receptor activity
• protein binding
• cytokine binding
• metal ion binding
|
| Cellular component |
• external side of plasma membrane
• integral to membrane
|
| Biological process |
• adaptive immune response
• monocyte chemotaxis
• signal transduction
• cell-cell signaling
• positive regulation of cell proliferation
• osteoclast differentiation
• response to lipopolysaccharide
• tumor necrosis factor-mediated signaling pathway
• response to cytokine stimulus
• response to tumor necrosis factor
• positive regulation of I-kappaB kinase/NF-kappaB cascade
• positive regulation of JUN kinase activity
• positive regulation of sequence-specific DNA binding transcription factor activity
• positive regulation of NF-kappaB transcription factor activity
• circadian temperature homeostasis
• response to interleukin-1
• positive regulation of fever generation by positive regulation of prostaglandin secretion
• TNFSF11-mediated signaling pathway
• positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling
|
| Sources: <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> Amigo / <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> QuickGO |
|
| RNA expression pattern |
|
| More reference expression data |
| Orthologs |
| Species |
Human |
Mouse |
|
| Entrez |
8792 |
21934 |
|
| Ensembl |
ENSG00000141655 |
ENSMUSG00000026321 |
|
| UniProt |
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> |
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"><head><title>Jobs</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/><link href="/" rel="home"/><link href="http://creativecommons.org/licenses/by-nd/3.0/" rel="license"/><link type="image/vnd.microsoft.icon" href="/favicon.ico" rel="shortcut icon"/><link href="/css-compr.css2013_11" type="text/css" rel="stylesheet"/> |
|
| RefSeq (mRNA) |
NM_001270949 |
NM_009399 |
|
| RefSeq (protein) |
NP_001257878 |
NP_033425 |
|
| Location (UCSC) |
Chr 18:
59.99 – 60.06 Mb |
Chr 1:
105.78 – 105.85 Mb |
|
| PubMed search |
[1] |
[2] |
|
|
|
Receptor Activator of Nuclear Factor κ B (RANK), also known as TRANCE Receptor, is a type I membrane protein that is expressed on the surface of osteoclasts and is involved in their activation upon ligand binding. RANK is also expressed on dendritic cells and facilitates immune signaling.
RANKL (Receptor Activator for Nuclear Factor κ B Ligand) is found on the surface of stromal cells, osteoblasts, and T cells. [1] [2] [3]
Contents
- 1 Interactions
- 2 See also
- 3 References
- 4 External links
- 5 Further reading
Interactions[edit]
RANK has been shown to interact with TRAF6,[4][5][6][7][8] TRAF5,[5][6][7] TRAF1,[7][8] TRAF2[5][6][7][8] and TRAF3.[7][8]
See also[edit]
- RANKL
- Osteoprotegerin
- Osteoimmunology
References[edit]
- ^ Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999). "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families". Endocr. Rev. 20 (3): 345–57. doi:10.1210/er.20.3.345. PMID 10368775.
- ^ Wong BR, Josien R, Choi Y (1999). "TRANCE is a TNF family member that regulates dendritic cell and osteoclast function". J. Leukoc. Biol. 65 (6): 715–24. PMID 10380891.
- ^ Theill LE, Boyle WJ, Penninger JM (2002). "RANK-L and RANK: T cells, bone loss, and mammalian evolution". Annu. Rev. Immunol. 20: 795–823. doi:10.1146/annurev.immunol.20.100301.064753. PMID 11861618.
- ^ Mizukami, Junko; Takaesu Giichi, Akatsuka Hiroyuki, Sakurai Hiroaki, Ninomiya-Tsuji Jun, Matsumoto Kunihiro, Sakurai Naoki (Feb 2002). "Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6". Mol. Cell. Biol. (United States) 22 (4): 992–1000. doi:10.1128/MCB.22.4.992-1000.2002. ISSN 0270-7306. PMC 134634. PMID 11809792.
- ^ a b c Darnay, B G; Haridas V, Ni J, Moore P A, Aggarwal B B (Aug 1998). "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase". J. Biol. Chem. (UNITED STATES) 273 (32): 20551–5. doi:10.1074/jbc.273.32.20551. ISSN 0021-9258. PMID 9685412.
- ^ a b c Darnay, B G; Ni J, Moore P A, Aggarwal B B (Mar 1999). "Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif". J. Biol. Chem. (UNITED STATES) 274 (12): 7724–31. doi:10.1074/jbc.274.12.7724. ISSN 0021-9258. PMID 10075662.
- ^ a b c d e Galibert, L; Tometsko M E, Anderson D M, Cosman D, Dougall W C (Dec 1998). "The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily". J. Biol. Chem. (UNITED STATES) 273 (51): 34120–7. doi:10.1074/jbc.273.51.34120. ISSN 0021-9258. PMID 9852070.
- ^ a b c d Kim, H H; Lee D E, Shin J N, Lee Y S, Jeon Y M, Chung C H, Ni J, Kwon B S, Lee Z H (Jan 1999). "Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase". FEBS Lett. (NETHERLANDS) 443 (3): 297–302. doi:10.1016/S0014-5793(98)01731-1. ISSN 0014-5793. PMID 10025951.
External links[edit]
- RANK Protein at the US National Library of Medicine Medical Subject Headings (MeSH)
Further reading[edit]
- Romas E, Gillespie MT, Martin TJ (2002). "Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.". Bone 30 (2): 340–6. doi:10.1016/S8756-3282(01)00682-2. PMID 11856640.
- Collin-Osdoby P (2005). "Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.". Circ. Res. 95 (11): 1046–57. doi:10.1161/01.RES.0000149165.99974.12. PMID 15564564.
- Clohisy DR, Mantyh PW (2005). "Bone cancer pain and the role of RANKL/OPG.". Journal of musculoskeletal & neuronal interactions 4 (3): 293–300. PMID 15615497.
- Anandarajah AP, Schwarz EM (2006). "Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications.". J. Cell. Biochem. 97 (2): 226–32. doi:10.1002/jcb.20674. PMID 16240334.
- Baud'huin M, Duplomb L, Ruiz Velasco C, et al. (2007). "Key roles of the OPG-RANK-RANKL system in bone oncology.". Expert Rev Anticancer Ther 7 (2): 221–32. doi:10.1586/14737140.7.2.221. PMID 17288531.
- Boyce BF, Xing L (2007). "Biology of RANK, RANKL, and osteoprotegerin.". Arthritis Res. Ther. 9 Suppl 1: S1. doi:10.1186/ar2165. PMC 1924516. PMID 17634140.
- Hughes AE, Shearman AM, Weber JL, et al. (1994). "Genetic linkage of familial expansile osteolysis to chromosome 18q.". Hum. Mol. Genet. 3 (2): 359–61. doi:10.1093/hmg/3.2.359. PMID 7911698.
- Cody JD, Singer FR, Roodman GD, et al. (1997). "Genetic linkage of Paget disease of the bone to chromosome 18q.". Am. J. Hum. Genet. 61 (5): 1117–22. doi:10.1086/301601. PMC 1716035. PMID 9345096.
- Anderson DM, Maraskovsky E, Billingsley WL, et al. (1997). "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.". Nature 390 (6656): 175–9. doi:10.1038/36593. PMID 9367155.
- Haslam SI, Van Hul W, Morales-Piga A, et al. (1998). "Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity.". J. Bone Miner. Res. 13 (6): 911–7. doi:10.1359/jbmr.1998.13.6.911. PMID 9626621.
- Darnay BG, Haridas V, Ni J, et al. (1998). "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.". J. Biol. Chem. 273 (32): 20551–5. doi:10.1074/jbc.273.32.20551. PMID 9685412.
- Wong BR, Josien R, Lee SY, et al. (1998). "The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.". J. Biol. Chem. 273 (43): 28355–9. doi:10.1074/jbc.273.43.28355. PMID 9774460.
- Galibert L, Tometsko ME, Anderson DM, et al. (1999). "The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.". J. Biol. Chem. 273 (51): 34120–7. doi:10.1074/jbc.273.51.34120. PMID 9852070.
- Nakagawa N, Kinosaki M, Yamaguchi K, et al. (1999). "RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.". Biochem. Biophys. Res. Commun. 253 (2): 395–400. doi:10.1006/bbrc.1998.9788. PMID 9878548.
- Kim HH, Lee DE, Shin JN, et al. (1999). "Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.". FEBS Lett. 443 (3): 297–302. doi:10.1016/S0014-5793(98)01731-1. PMID 10025951.
- Darnay BG, Ni J, Moore PA, Aggarwal BB (1999). "Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.". J. Biol. Chem. 274 (12): 7724–31. doi:10.1074/jbc.274.12.7724. PMID 10075662.
- Hsu H, Lacey DL, Dunstan CR, et al. (1999). "Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.". Proc. Natl. Acad. Sci. U.S.A. 96 (7): 3540–5. doi:10.1073/pnas.96.7.3540. PMC 22329. PMID 10097072.
- Dougall WC, Glaccum M, Charrier K, et al. (1999). "RANK is essential for osteoclast and lymph node development.". Genes Dev. 13 (18): 2412–24. doi:10.1101/gad.13.18.2412. PMC 317030. PMID 10500098.
- Hughes AE, Ralston SH, Marken J, et al. (2000). "Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.". Nat. Genet. 24 (1): 45–8. doi:10.1038/71667. PMID 10615125.
- Wong BR, Besser D, Kim N, et al. (2000). "TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.". Mol. Cell 4 (6): 1041–9. doi:10.1016/S1097-2765(00)80232-4. PMID 10635328.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
Cytokine receptors
|
|
Chemokine receptor
(GPCRs) |
| CC |
- CCR1 / CCRL1
- CCR2
- CCRL2
- CCR3
- CCR4
- CCR5
- CCR6
- CCR7
- CCR8
- CCR9
- CCR10
|
|
| CXC |
- IL-8
- CXCR3
- CXCR4
- CXCR5
- CXCR6
- CXCR7
|
|
| Other |
|
|
|
| TNF receptor |
| 1-10 |
- TNFRSF1 (CD120)
- TNFRSF1A (CD120a)
- TNFRSF1B (CD120b)
- TNFRSF3 (Lymphotoxin beta receptor)
- TNFRSF4 (CD134)
- TNFRSF5 (CD40)
- TNFRSF6 (FAS)
- TNFRSF6B
- TNFRSF7 (CD27)
- TNFRSF8 (CD30)
- TNFRSF9 (CD137)
|
|
| 11-20 |
- TNFRSF10A (CD261)
- TNFRSF10B (CD262)
- TNFRSF10C (CD263)
- TNFRSF10D (CD264)
- TNFRSF11A (CD265/RANK)
- TNFRSF11B (Osteoprotegerin)
- TNFRSF12A (CD266)
- TNFRSF13B (CD267)
- TNFRSF13C
- TNFRSF14 (CD268)
- TNFRSF16 (Nerve growth factor receptor)
- TNFRSF17 (CD269)
- TNFRSF18
- TNFRSF19
|
|
| 21-25 |
- TNFRSF21
- TNFRSF25
- TNFRSF27
|
|
|
| JAK-STAT |
| Type I |
| γ-chain |
- Interleukin receptors
- IL2R / IL2RA/IL2RB / IL15R
- IL4R / IL13R / IL13RA1 / IL13RA2
- IL7R / IL7RA
- IL9R
- IL21R
|
|
| β-chain |
- Interleukin receptors
- IL3R / IL3RA
- IL5R / IL5RA
- GM-CSF
|
|
| gp130 |
- Interleukin receptors
- IL6RA
- 11/IL11RA
- 27/IL27RA
- OSMR
- LIFR
- CNTFR
|
|
| IL12RB1 |
- Interleukin receptors
- IL12R/IL12RB1/IL12RB2
- IL23R23
|
|
| Other |
- hormone receptor: GH
- prolactin
|
|
|
| Type II |
- Interleukin receptors
- IL10R / IL10RA / IL10RB / IL22R / IL22RA1 / IL22RA2
- IL20R / IL20RA / IL20RB
- IL28R
- Interferon receptors
- -α/β / IFNAR1/IFNAR2
- -γ/IFNGR1 / IFNGR2
|
|
|
| Ig superfamily |
- CSF1
- KIT
- IL1
- IL18R / IL18R1
|
|
| IL 17 family |
- IL-17
- IL17RA
- IL17RB
- IL17RC
- IL17RD
- IL17RE
|
|
| S/T |
|
|
|
B trdu: iter (nrpl/grfl/cytl/horl), csrc (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd; path (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 骨粗鬆症に対するデノスマブdenosumab for osteoporosis [show details]
…function of bone-resorbing osteoclasts. RANKL interacts with a receptor (RANK) on both osteoclast precursors and osteoclasts. The RANKL/RANK interaction results in activation, migration, differentiation, and …
- 2. 骨格の正常な発達および骨形成ならびに骨吸収の調節normal skeletal development and regulation of bone formation and resorption [show details]
… precursors that is identical to the receptor involved in interaction of T-cells and dendritic cells called RANK NFATc1 is induced by RANKL and coactivated by immunoglobulin-like receptors and their associated …
- 3. 骨転移の機序mechanisms of bone metastases [show details]
…cells can activate osteoclastic bone resorption in a number of ways. The receptor activator of nuclear factor kappa-B (RANK)/RANK ligand (RANKL) signaling pathway is a major regulator of both normal and …
- 4. 骨の巨大細胞腫瘍giant cell tumor of bone [show details]
…treatment with denosumab. The characterization of the role of the RANK (receptor activator of nuclear factor kappa B [NF-kB])/RANK ligand (RANKL) axis in mediating the recruitment and function of osteoclast-like …
- 5. 多発性骨髄腫：病理生物学的特徴multiple myeloma pathobiology [show details]
…activating factors such as lymphotoxin, IL-6, hepatocyte growth factor, and receptor activator of nuclear factor kappa B ligand (RANK ligand). Renal involvement in MM is usually the result of monoclonal …
English Journal
- Long-term outcome of patients with liver cirrhosis admitted to a general intensive care unit.
- Warren A1, Soulsby CR1, Puxty A2, Campbell J1, Shaw M3, Quasim T1,2, Kinsella J1, McPeake J4,5.
- Annals of intensive care.Ann Intensive Care.2017 Dec;7(1):37. doi: 10.1186/s13613-017-0257-6. Epub 2017 Apr 4.
- PMID 28374334
- IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study.
- Jiménez-Sousa MA1, Medrano LM2, Liu P3, Fernández-Rodríguez A2, Almansa R4, Gomez-Sanchez E3, Ortega A4, Heredia-Rodríguez M3, Gómez-Pesquera E3, Tamayo E3, Resino S5.
- Annals of intensive care.Ann Intensive Care.2017 Dec;7(1):22. doi: 10.1186/s13613-017-0247-8. Epub 2017 Feb 28.
- PMID 28247301
- MLAA-based attenuation correction of flexible hardware components in hybrid PET/MR imaging.
- Heußer T1, Rank CM2, Berker Y3,4, Freitag MT5, Kachelrieß M2.
- EJNMMI physics.EJNMMI Phys.2017 Dec;4(1):12. doi: 10.1186/s40658-017-0177-4. Epub 2017 Mar 1.
- PMID 28251575
Japanese Journal
- Validity of a Self-Administered Food-Frequency Questionnaire for Assessing Amino Acid Intake in Japan: Comparison With Intake From 4-Day Weighed Dietary Records and Plasma Levels
- Iwasaki Motoki,Ishihara Junko,Takachi Ribeka,Todoriki Hidemi,Yamamoto Hiroshi,Miyano Hiroshi,Yamaji Taiki,Tsugane Shoichiro
- Journal of Epidemiology advpub(0), 2016
- … Plasma levels of amino acids were measured using the UF-Amino Station system.<BR>Results: Spearman rank correlation coefficients of energy-adjusted intake of amino acids from the DR and FFQ ranged from 0.40 to 0.65 for men and from 0.35 to 0.46 for women. …
- NAID 130005092274
- 疾患からみた細胞表面機能分子(第5回)骨破壊におけるRANK/RANKL
- Effectiveness of Approximation Strategy in Surrogateassisted Fireworks Algorithm
- Pei Yan,Zheng Shaoqiu,Tan Ying,Takagi Hideyuki
- International Journal of Machine Learning and Cybernetics 2015(7), 2015-07-14
- … The advantages of the fireworks algorithm, a number of open topics, and new discoveries arising from evaluation results, such as multi-production mechanism of the fireworks algorithm, optimization performance of each method, elite rank, interpolation times and extrapolation times of elites are analyzed and discussed. …
- NAID 120005624070
Related Links
- RANK関数を使用してテスト受験者の順位を返す 以下の表では英語テスト受験者のテスト点数からそれぞれの受験者の順位を返しています。 C2に=RANK(B2,$B$2:$B$6) C3に=RANK(B3,$B$2:$B$6) C4に=RANK(B4,$B$2:$B$6) C5に=RANK ...
- エクセル初心者でも使えるExcel関数について順番に説明していきます。今回は順位をつけるRANK関数の使い方です。 ... 元となる表作成をします 1.中間試験の点数を入れます 2.表をアレンジします 題名はフォントサイズを大きくし、太字 ...
★リンクテーブル★
[★]
- 英
- receptor activator of nuclear factor-kappaB、receptor activator of nuclear factor-kappa B、RANK
- 関
- NF-κB活性化受容体
[★]
NFκB活性化受容体
- 関
- RANK、receptor activator of nuclear factor-kappa B
[★]
- 関
- osteoclast differentiation factor、receptor activator of NF-kappaB ligand
- 同
- receptor activator for nuclear factor kB ligand
[★]
- 英
- RANK ligand
- 関
- ランクリガンド
[★]
- 地位、順位。下級、投球
- 後位、養殖
- 列、並び。整列
- 並べる、整列させる。(～と)並べる、同列にする
- ～に等級(順位)をつける、ランク付けをする。評価する。分類する。
- ～より階級が上だ、～の上に立つ
- 位する、ランク付けされる。評価される。列する、並ぶ
- 上位を占める
- 整列する
- 関
- lie、locate、location、loci、locus、map、position、ranking、sit、situated、situation、stand、topo
[★]